HSF Danby Research Grant Program
HSF Danby Research Grant Program supports investigators conducting new clinical and translational research into hidradenitis suppurativa to improve patient care and raise disease awareness.
Browse similar grants
Funder: Hidradenitis Suppurativa Foundation
Due Dates: December 7, 2026, at midnight (Application deadline)
Funding Amounts: Up to $30,000 in direct costs for one year; up to four awards annually
Summary: Supports new clinical and translational research into hidradenitis suppurativa to improve patient care.
Key Information: Only investigators working in the United States are eligible; early-stage investigators receive priority.
Description
The HSF Danby Research Grant Program is run by the Hidradenitis Suppurativa Foundation to develop new clinical and translational lines of investigation into hidradenitis suppurativa (HS). It supports research that advances patient care, combines innovation with well-reasoned methods and analyses, and establishes its significance in relation to existing knowledge.
The program values projects that could attract additional funding, directly affect patient care, or raise disease awareness. Reviewers consider investigators’ ability to accomplish the proposed aims, diversity within research teams and planned patient cohorts, and attention to potential problems, alternative strategies, and benchmarks for success. Clinical trials are strongly discouraged because the grant’s funding level is likely inadequate to support a robust trial.
